SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-051464
Filing Date
2022-09-28
Accepted
2022-09-28 16:43:12
Documents
2
Period of Report
2022-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1650
2 POA DOCUMENT poa.txt EX-24 4666
  Complete submission text file 0001209191-22-051464.txt   7763
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address
Gandhi Mayank (Reporting) CIK: 0001832725 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39866 | Film No.: 221276603